Browse our anti-RPS6KA6 (RPS6KA6) Antibodies

Full name:
anti-Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 6 Antibodies (RPS6KA6)
On are 44 Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 6 (RPS6KA6) Antibodies from 13 different suppliers available. Additionally we are shipping RPS6KA6 Proteins (8) and many more products for this protein. A total of 58 RPS6KA6 products are currently listed.
2610524K04Rik, PP90RSK4, rps6ka6, RSK4, wu:fj94b02, zgc:66139
list all antibodies Gene Name GeneID UniProt
RPS6KA6 67071 Q7TPS0
RPS6KA6 27330 Q9UK32

Show all species

Show all synonyms

Most Popular Reactivities for anti-RPS6KA6 (RPS6KA6) Antibodies

Select your species and application

anti-Mouse (Murine) RPS6KA6 Antibodies:

anti-Human RPS6KA6 Antibodies:

anti-Monkey RPS6KA6 Antibodies:

All available anti-RPS6KA6 Antibodies

Go to our pre-filtered search.

Top referenced anti-RPS6KA6 Antibodies

  1. Human Polyclonal RPS6KA6 Primary Antibody for IHC, ELISA - ABIN1534185 : Ross, Grafham, Coffey, Scherer, McLay, Muzny, Platzer, Howell, Burrows, Bird, Frankish, Lovell, Howe, Ashurst, Fulton, Sudbrak, Wen, Jones, Hurles, Andrews, Scott, Searle, Ramser, Whittaker, Deadman et al.: The DNA sequence of the human X chromosome. ... in Nature 2005 (PubMed)
    Show all 2 references for 1534185

  2. Human Polyclonal RPS6KA6 Primary Antibody for IHC (p), WB - ABIN1882127 : Yntema, van den Helm, Kissing, van Duijnhoven, Poppelaars, Chelly, Moraine, Fryns, Hamel, Heilbronner, Pander, Brunner, Ropers, Cremers, van Bokhoven: A novel ribosomal S6-kinase (RSK4; RPS6KA6) is commonly deleted in patients with complex X-linked mental retardation. in Genomics 2000 (PubMed)
    Show all 2 references for 1882127

More Antibodies against RPS6KA6 Interaction Partners

Mouse (Murine) Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 6 (RPS6KA6) interaction partners

  1. Rsk4 inhibits the transcriptional activation of specific targets of receptor tyrosine kinase (show ERBB3 Antibodies) signaling as well as the activation of ERK (show EPHB2 Antibodies)

Human Ribosomal Protein S6 Kinase, 90kDa, Polypeptide 6 (RPS6KA6) interaction partners

  1. RSK4 is expressed at low levels in malignant ovarian tumors, which correlates with advanced stages of the disease.

  2. downregulation of RSK4 expression is indicated to be associated with tumor cell proliferation and invasion, and silencing of the RSK4 may be involved in the development and progression of breast cancer

  3. Low RSK4 expression is correlated with advanced clinical pathologic classifications and is a poor overall survival in colorectal cancer patients

  4. RSK4 mRNA is significantly decreased in most of breast cancer tissues compared with paired non-cancerous tissues, due to promoter hypermethylation; frequent epigenetic inactivation might have a role in precancerous lesions or early cancer

  5. evaluated expression of RSK4 in renal cell carcinoma (show MOK Antibodies)(RCC (show XRCC1 Antibodies))tissues, analysed relationship between RSK4 expression and clinicopathological features of RCC (show XRCC1 Antibodies) patients and explored potential molecular mechanisms of RSK4 in RCC (show XRCC1 Antibodies) cell lines; expression pattern and molecular mechanisms of RSK4 in RCCs indicate it could be a potential independent prognostic factor

  6. Overexpression of RSK3 (show RPS6KA2 Antibodies) or RSK4 supports tumor cell proliferation upon PI3K (show PIK3CA Antibodies) inhibition both in vitro and in vivo therby contributing to drug resistance.

  7. findings reveals a major role of PRKX (show PRKX Antibodies), TTBK2 (show TTBK2 Antibodies) and RSK4 in triggering Sunitinib resistance formation; data suggest transcriptional regulation of these kinases together with other proteins might play an important role in formation of Sunitinib resistance by affecting transcription factors

  8. Suggest that RSK4 may serve as a mediator of endothelial progenitor cell senescence in diabetes mellitus.

  9. The expression level of RSK-4 mRNA in breast cancer was significantly lower than those in normal breast tissues and breast benign lesions tissues. The down-regulation of RSK-4 expression in breast caner suggests that it is a breast cancer suppressor gene.

  10. Data indicate that RSK4 appears to be epigenetically silenced in endometrial cancer as evidenced by hypermethylation.

RPS6KA6 Antigen Profile

Antigen Summary

This gene encodes a member of ribosomal S6 kinase family, serine-threonine protein kinases which are regulated by growth factors. The encoded protein may be distinct from other members of this family, however, as studies suggest it is not growth factor dependent and may not participate in the same signaling pathways.

Alternative names and synonyms associated with RPS6KA6

  • ribosomal protein S6 kinase polypeptide 6 (Rps6ka6) antibody
  • ribosomal protein S6 kinase, 90kDa, polypeptide 6 (RPS6KA6) antibody
  • ribosomal protein S6 kinase, like (rps6kal) antibody
  • 2610524K04Rik antibody
  • PP90RSK4 antibody
  • rps6ka6 antibody
  • RSK4 antibody
  • wu:fj94b02 antibody
  • zgc:66139 antibody

Protein level used designations for RPS6KA6

S6K-alpha-6 , ribosomal protein S6 kinase alpha-6 , 90 kDa ribosomal protein S6 kinase 6 , RSK-4 , S6K-alpha 6 , p90-RSK 6 , p90RSK6 , ribosomal S6 kinase 4 , S6K-alpha 6-like , ribosomal protein S6 kinase polypeptide 6

67071 Mus musculus
27330 Homo sapiens
337670 Danio rerio
Selected quality suppliers for anti-RPS6KA6 (RPS6KA6) Antibodies
Did you look for something else?